Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by R-pharm, explained in plain language.
This study tested a biosimilar drug called RPH-002, which is a copy of the cancer drug Erbitux, in 118 people with advanced head and neck cancer that could not be removed by surgery. The main goal was to see if the body processes RPH-002 the same way as Erbitux and to check for s…
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jun 24, 2026 03:16 UTC